Westchester Capital Management (New York)’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Westchester Capital Management (New York)’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-175,897	Closed	-$20.8M	–	413
2021 Q1	$20.8M	Buy	+175,897	New	+$20.8M	0.58%	29

Westchester Capital Management (New York)'s CBPO Position: Q2 2021 in Review

Westchester Capital Management (New York) sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 175,897 shares — an estimated $20.8M sold.

Westchester Capital Management (New York) first reported a position in CBPO in Q1 2021 and held it in 1 quarter. The position peaked at $20.8M in Q1 2021. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

Westchester Capital Management (New York) reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
Westchester Capital Management (New York) sold 175,897 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $20.8M.
Westchester Capital Management (New York) first reported a position in China Biologic Products Holdings, Inc. in Q1 2021 and held it in 1 quarter.
Westchester Capital Management (New York)'s China Biologic Products Holdings, Inc. position peaked at $20.8M in Q1 2021.
0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on Westchester Capital Management (New York)'s 13F filing for Q2 2021, filed 13 Aug 2021.